Metronidazole for the treatment of vaginal infections

Bibliography

• ACOG Practice Bulletin #72
   Google Scholar
• Sobel JD. Vulvovaginitis in healthy women. Compr Ther 1999;25:335-46
   PubMedGoogle Scholar
• Salvatore M, Meyers BR. Metronidazole. Chapter 29 In: Principles and practices of infectious diseases edit. 7th edition. Bennetian Delin; Mandell: 2010. p. 419-26
   Google Scholar
• Hanson JM, McGregor JA, Hillier SL, et al. Metronidazole for bacterial vaginosis. A comparison of vaginal gel vs. oral therapy. J Reprod Med 2000;45(11):889-96
   PubMed Web of Science ®Google Scholar
• Kurohara ML, Kwong FK, Lebherz TB, Klaustermeyer WB. Metronidazole hypersensitivity and oral desensitization. J Allergy Clin Immunol 1991;88:279-80
   PubMedGoogle Scholar
• Kenyon C, Colebunders R, Crucitti T. The global epidemiology of bacterial vaginosis: a systematic review. Am J Obstet Gynecol 2013;209(6):505-23
   PubMed Web of Science ®Google Scholar
• Hill GB. The microbiology of bacterial vaginosis. Am J Obstet Gynecol 1993;169:450-4
   PubMed Web of Science ®Google Scholar
• Ling Z, Kong J, Liu F, et al. Molecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis. BMC Genomics 2010;11:488
   PubMed Web of Science ®Google Scholar
• Eschenbach DA, Davick PR, Williams BL, et al. Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol 1989;27:251-6
   PubMed Web of Science ®Google Scholar
• Lamont RF, Sobel JD, Akins RA, et al. The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG 2011;118:533-49
   PubMed Web of Science ®Google Scholar
• Swidsinski A, Mendling W, Loening-Baucke V, et al. Adherent biofilms in bacterial vaginosis. Obstet Gynecol 2005;106:1013-23
   PubMed Web of Science ®Google Scholar
• Swidsinski A, Doerffel Y, Loening-Baucke V, et al. Gardnerella biofilm involves females and males and is transmitted sexually. Gynecol Obstet Invest 2010;70:256-63
   PubMed Web of Science ®Google Scholar
• Alves P, Castro J, Sousa C, et al. Gardnerella vaginalis outcompetes 29 other bacterial species isolated from patients with bacterial vaginosis, using in an in vitro biofilm formation model. J Infect Dis 2014;210:593-6
   PubMed Web of Science ®Google Scholar
• Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 2005;353:1899-911
   PubMed Web of Science ®Google Scholar
• Fredricks DN, Fiedler TL, Thomas KK, et al. Targeted PCR for detection of vaginal bacteria associated with bacterial vaginosis. J Clin Microbiol 2007;45:3270-6
   PubMed Web of Science ®Google Scholar
• Klebanoff MA, Hauth JC, MacPherson CA, et al. Time course of the regression of asymptomatic bacterial vaginosis in pregnancy with and without treatment. AM J Obstet Gynecol 2004;190:363-70
   PubMed Web of Science ®Google Scholar
• Workowski KA, Berman S; Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010;59:1
   PubMedGoogle Scholar
• Klebanoff MA, Hillier SL, Nugent RP, et al. Is bacterial vaginosis a stronger risk factor for preterm birth when it is diagnosed earlier in gestation? Am J Obstet Gynecol 2005;192:470-7
   PubMed Web of Science ®Google Scholar
• Flynn CA, Helwig AL, Meurer LN. Bacterial vaginosis in pregnancy and the risk of prematurity: a meta-analysis. J Fam Pract 1999;48:885-92
   PubMed Web of Science ®Google Scholar
• Hauth JC, Macpherson C, Carey JC, et al. Early pregnancy threshold vaginal pH and Gram stain scores predictive of subsequent preterm birth in asymptomatic women. Am J Obstet Gynecol 2003;188(3):831-5
   PubMed Web of Science ®Google Scholar
• UK national guideline for the management of bacterial vaginosis. 2012
   Google Scholar
• Oduyebo OO, Anorlu RI, Ogunsola FT. The effects of antimicrobial therapy on bacterial vaginosis in non-pregnant women. Cochrane Database Syst Rev 2009;CD006055
   PubMedGoogle Scholar
• Swedberg J, Steiner JF, Deiss F, et al. Comparison of single-dose vs on-week course of metronidazole for symptomatic bacterial vaginosis. JAMA 1985;254:1046-9
   PubMed Web of Science ®Google Scholar
• Aguin T, Akins RA, Sobel JD. High dose metronidazole for recurrent bacterial vaginosis – a pilot study. J Low Genit Tract Dis 2014;18(2):156-61
   PubMedGoogle Scholar
• European (International Union against Sexually Transmitted Infections [IUSTI] World Health Organization [WHO]) Guideline on the Management of Vaginal Discharge. 2011
   Google Scholar
• Bradshaw CS, Morton AN, Hocking JS, et al. High recurrence rate of bacterial vaginosis over the curse of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 2006;193:1478-86
   PubMed Web of Science ®Google Scholar
• Bradshaw CS, Vodsheil LA, Hocking JS, et al. Recurrence of bacterial vaginosis is significantly associated with post treatment sexual activities and hormonal contraceptive. Clin Infect Dis 2013;56:777-86
   PubMed Web of Science ®Google Scholar
• Smith JA. Neutropenia associated with metronidazole therapy. CMAJ 1980;123:202-4
   PubMedGoogle Scholar
• Sobel ID, Ferris D, Schwebke J, et al. Suppressive antibacterial therapy with 0.15% Metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol 2006;194:1283-9
   PubMed Web of Science ®Google Scholar
• Aguin T, Akins RA, Sobel JD. High dose vaginal maintenance metronidazole for recurrent bacterial vaginosis: a pilot study. Sex Transm Dis 2014;41:290-1
   PubMedGoogle Scholar
• Reichman O, Sobel JD. Boric acid addition to suppressive antimicrobial therapy for recurrent bacterial vaginosis. Sex Transm Dis 2009;36:732-4
   PubMed Web of Science ®Google Scholar
• Sutton M, Sternberg M, Koumans EH, et al. The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004. Clin Infect Dis 2007;45:1319-26
   PubMed Web of Science ®Google Scholar
• Meites E, Llata E, Braxton J, et al. Trichomonas vaginalis in selected U.S. sexually transmitted disease clinics: testing, screening, and prevalence. Sex Transm Dis 2013;40:865-9
   PubMedGoogle Scholar
• Schwebke JR, Burgess D. Trichomoniasis. Clin Microbiol Rev 2004;17:794-803
   PubMed Web of Science ®Google Scholar
• Hager WD, Brown ST, Kraus SJ, et al. Metronidazole for vaginal trichomoniasis. Seven-day vs single dose regimens. JAMA 1980;244:1219-20
   PubMed Web of Science ®Google Scholar
• Manorama HT, Shenoy DR. Single-dose oral treatment of vaginal trichomoniasis with tinidazole and metronidazole. J Int Med Res 1978;6:46-9
   PubMed Web of Science ®Google Scholar
• Forna F, Gulmezoglu AM. Interventions for treating trichomoniasis in women. Cochrane Database Syst Rev 2003;CD000218
   PubMedGoogle Scholar
• Thin RN, Symonds MA, Booker R, et al. Double-blind comparison of a single dose and a five-day course of metronidazole in the treatment of trichomoniasis. Br J Vener Dis 1979;55:354-6
   PubMedGoogle Scholar
• Schwebke JR, Lensing SY, Sobel J. Intravaginal metronidazole/miconazole for the treatment of vaginal trichomoniasis. Sex Transm Dis 2014;40:710-14
   Google Scholar
• Koss CA, Baras DC, Lane SD, et al. Investigation of metronidazole use during pregnancy and adverse birth outcomes. Antimicrob Agents Chemother 2012;56:4800-5
   PubMed Web of Science ®Google Scholar
• Okun N, Gronau KA, Hannah ME. Antibiotics for bacterial vaginosis or Trichomonas vaginalis in pregnancy: a systematic review. Obstet Gynecol 2005;105:857-68
   PubMed Web of Science ®Google Scholar
• Klebanoff MA, Carey JC, Hauth JC, et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 2001;345:487-93
   PubMed Web of Science ®Google Scholar
• Kissinger P, Mena L, Levison J, et al. A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women. J Acquir Immune Defic Syndr 2010;55:565-71
   PubMedGoogle Scholar
• Knowles S, Choudhury T, Shear NH. Metronidazole hypersensitivity. Ann Pharmacother 1994;28:325-6
   PubMed Web of Science ®Google Scholar
• Garcia-Rubio I, Martinez-Cocera C, Santos Magadan S, et al. Hypersensitivity reactions to metronidazole. Allergol Immunopathol (Madr) 2006;34:70-2
   PubMedGoogle Scholar
• Asensio Sanchez T, Davila I, Moreno E, et al. Anaphylaxis due to metronidazole with positive skin prick test. J Investig Allergol Clin Immunol 2008;18:138-9
   PubMed Web of Science ®Google Scholar
• Short KA, Fuller LC, Salisbury JR. Fixed drug eruption following metronidazole therapy and the use of topical provocation testing in diagnosis. Clin Exp Dermatol 2002;27:464-6
   PubMedGoogle Scholar
• Helms DJ, Mosure DJ, Secor WE, Workowski KA. Management of Trichomonas vaginalis in women with suspected metronidazole hypersensitivity. Am J Obstet Gynecol 2008;198:370-4
   PubMedGoogle Scholar